It was found that elevated NF-L levels were associated with a 3-fold increase in the risk of developing severe MS, as estimated by bivariate and multivariate logistic regression analysis, particularly among cases with RR-MS and cases with a recent relapse. Here, NEFL is linked to myeloid sarcoma.